-+ 0.00%
-+ 0.00%
-+ 0.00%

CareDx completes sale of lab products unit to Eurobio Scientific for $171.2 million cash

PUBT·06/30/2026 20:06:18
Listen to the news
CareDx completes sale of lab products unit to Eurobio Scientific for $171.2 million cash
  • CareDx completed the sale of its Lab Products business to Eurobio Scientific, with closing on June 30, 2026.
  • CareDx received USD 171.2 million in cash at closing, subject to customary post-closing adjustments.
  • The divested unit sells IVD kits and assays for HLA typing and transplant monitoring, primarily outside North America.
  • The deal refocuses CareDx on U.S. precision medicine testing services and patient and digital solutions.
  • Additional detail on the financial impact is expected during the second-quarter 2026 earnings call.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CareDx Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260630207907) on June 30, 2026, and is solely responsible for the information contained therein.